Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
P129335-100mg
|
100mg |
3
|
$9.90
|
|
|
P129335-250mg
|
250mg |
5
|
$16.90
|
|
|
P129335-1g
|
1g |
3
|
$39.90
|
|
|
P129335-5g
|
5g |
3
|
$119.90
|
|
|
P129335-25g
|
25g |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$319.90
|
|
|
P129335-100g
|
100g |
2
|
$899.90
|
|
anti-inflammatory antifibrotic agent
| Synonyms | MFCD00866047 | Pirfenidona [INN-Spanish] | PIRFENIDONE [INN] | Pirfenidone(AMR69) | 5-Methyl-1-phenyl-2(1H)-pyridone | ESBRIET COMPONENT PIRFENIDONE | LP00907 | NCGC00024992-02 | 1-phenyl-5-methyl-2-pyridinone | DTXSID4045183 | NCGC00015806-05 | HMS3262F1 |
|---|---|
| Specifications & Purity | Moligand™, ≥98%(GC) |
| Biochemical and Physiological Mechanisms | Pirfenidone inhibits collagen production and fibroblast proliferation. It has shown antifibrotic and anti-inflammatory properties in variety of animal models of pulmonary fibrosis, and in clinical trials.Orally active anti-inflammatory, antifibrotic and a |
| Shipped In | Normal |
| Grade | Moligand™ |
| Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
| Product Description |
Application: Pyrfenidone is used for: Explanation: Pyrfenidone (5-methyl-1-phenyl-2- [1H] - pyridone) is a synthesized pyridine derivative. |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Pyridines and derivatives |
| Subclass | Hydropyridines |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Pyridinones |
| Alternative Parents | Methylpyridines Dihydropyridines Benzene and substituted derivatives Heteroaromatic compounds Lactams Azacyclic compounds Organopnictogen compounds Organooxygen compounds Organonitrogen compounds Organic oxides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteromonocyclic compounds |
| Substituents | Dihydropyridine - Pyridinone - Methylpyridine - Monocyclic benzene moiety - Benzenoid - Heteroaromatic compound - Lactam - Azacycle - Organic nitrogen compound - Hydrocarbon derivative - Organic oxide - Organooxygen compound - Organonitrogen compound - Organopnictogen compound - Organic oxygen compound - Aromatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as pyridinones. These are compounds containing a pyridine ring, which bears a ketone. |
| External Descriptors | ring assembly - pyridone |
|
|
|
| ALogP | 1.9 |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Pubchem Sid | 488183324 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488183324 |
| IUPAC Name | 5-methyl-1-phenylpyridin-2-one |
| INCHI | InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3 |
| InChIKey | ISWRGOKTTBVCFA-UHFFFAOYSA-N |
| Smiles | CC1=CN(C(=O)C=C1)C2=CC=CC=C2 |
| Isomeric SMILES | CC1=CN(C(=O)C=C1)C2=CC=CC=C2 |
| WGK Germany | 3 |
| RTECS | UV1148200 |
| Molecular Weight | 185.22 |
| Beilstein | 21(5)7,197 |
| Reaxy-Rn | 1526549 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=1526549&ln= |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | May 09, 2025 | P129335 | |
| Certificate of Analysis | May 09, 2025 | P129335 | |
| Certificate of Analysis | May 09, 2025 | P129335 | |
| Certificate of Analysis | May 09, 2025 | P129335 | |
| Certificate of Analysis | May 09, 2025 | P129335 | |
| Certificate of Analysis | Mar 04, 2025 | P129335 | |
| Certificate of Analysis | Jul 11, 2024 | P129335 | |
| Certificate of Analysis | Jul 11, 2024 | P129335 | |
| Certificate of Analysis | Jul 11, 2024 | P129335 | |
| Certificate of Analysis | Jul 10, 2024 | P129335 | |
| Certificate of Analysis | Jul 10, 2024 | P129335 | |
| Certificate of Analysis | Jul 10, 2024 | P129335 | |
| Certificate of Analysis | Jul 10, 2024 | P129335 | |
| Certificate of Analysis | Jul 10, 2024 | P129335 | |
| Certificate of Analysis | Jul 10, 2024 | P129335 | |
| Certificate of Analysis | Apr 02, 2024 | P129335 | |
| Certificate of Analysis | Dec 20, 2023 | P129335 | |
| Certificate of Analysis | Jul 07, 2023 | P129335 | |
| Certificate of Analysis | Jul 07, 2023 | P129335 | |
| Certificate of Analysis | Jul 07, 2023 | P129335 | |
| Certificate of Analysis | Jul 07, 2023 | P129335 | |
| Certificate of Analysis | Jul 07, 2023 | P129335 | |
| Certificate of Analysis | Dec 14, 2022 | P129335 | |
| Certificate of Analysis | Sep 17, 2022 | P129335 | |
| Certificate of Analysis | Sep 17, 2022 | P129335 | |
| Certificate of Analysis | Jul 18, 2022 | P129335 | |
| Certificate of Analysis | Jul 18, 2022 | P129335 | |
| Certificate of Analysis | Jul 18, 2022 | P129335 | |
| Certificate of Analysis | Jul 18, 2022 | P129335 | |
| Certificate of Analysis | Jun 24, 2022 | P129335 | |
| Certificate of Analysis | Jun 24, 2022 | P129335 | |
| Certificate of Analysis | Jan 25, 2022 | P129335 | |
| Certificate of Analysis | Dec 08, 2021 | P129335 | |
| Certificate of Analysis | Dec 08, 2021 | P129335 |
| Solubility | Soluble in water (>10 mg/ml at 60 °C), chloroform, DMSO (>20 mg/ml), ethanol, and DMF. |
|---|---|
| Melt Point(°C) | 107.0 to 111.0 °C |
| Molecular Weight | 185.220 g/mol |
| XLogP3 | 1.900 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 1 |
| Exact Mass | 185.084 Da |
| Monoisotopic Mass | 185.084 Da |
| Topological Polar Surface Area | 20.300 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 285.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
Starting at $36.90
| 1. Yin Zhang, Ranran Yu, Cheng Zhao, Jiawei Liang, Yixuan Zhang, Haochen Su, Jing Zhao, Hao Wu, Shijin Xu, Ziying Zhang, Lei Wang, Xiaoping Zou, Yun Zhu, Shu Zhang, Ying Lv. (2023) CAFs Homologous Biomimetic Liposome Bearing BET Inhibitor and Pirfenidone Synergistically Promoting Antitumor Efficacy in Pancreatic Ductal Adenocarcinoma. Advanced Science, (2305279). |
| 2. Huang Ting, Lin Ruyi, Su Yuanqin, Sun Hao, Zheng Xixi, Zhang Jinsong, Lu Xiaoyan, Zhao Baiqin, Jiang Xinchi, Huang Lingling, Li Ni, Shi Jing, Fan Xiaohui, Xu Donghang, Zhang Tianyuan, Gao Jianqing. (2023) Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesis. Nature Communications, 14 (1): (1-15). |
| 3. Xionghua Sun, Mei Zhu, Wei Xia, Xihan Xu, Jian Zhang, Xiaogang Jiang. (2023) Total sesquiterpenoids from Eupatorium lindleyanum DC. attenuate bleomycin-induced lung fibrosis by suppressing myofibroblast transition. FITOTERAPIA, 169 (105567). |
| 4. Xiaohua Xie, Xiaofeng Wu, Dongsheng Zhao, Ying Liu, Qiyue Du, Yitian Li, Yaping Xu, Yuhang Li, Yan Qiu, Yungang Yang. (2023) Fluvoxamine alleviates bleomycin-induced lung fibrosis via regulating the cGAS-STING pathway. PHARMACOLOGICAL RESEARCH, 187 (106577). |
| 5. Tingting Li, Dong Han, Zhongxian Li, Mengqi Qiu, Yuting Zhu, Kai Li, Jiawei Xiang, Huizhen Sun, Yahong Shi, Tun Yan, Xiaoli Shi, Qiang Zhang. (2022) Hydroxysafflor Yellow A Phytosomes Administered via Intervaginal Space Injection Ameliorate Pulmonary Fibrosis in Mice. Pharmaceuticals, 15 (11): (1394). |
| 6. Qi Fang, Shaoyu Liu, Jiangyu Cui, Ruiyue Zhao, Qian Han, Peng Hou, Youcai Li, Jie Lv, Xiaoyao Zhang, Qun Luo, Xinlu Wang. (2022) Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy. Frontiers in Bioengineering and Biotechnology, 10 (920766). |
| 7. Jian-Li Qiu, Guo-Feng Zhang, Yu-Na Chai, Xiao-Yan Han, Hai-Tao Zheng, Xiang-Feng Li, Fei Duan, Ling-Yan Chen. (2022) Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-β/Smad Signaling in an Animal Model of Biliary Atresia. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 381 (3): (257-265). |
| 8. Wei Sun, Zhe-li Jiang, Lei Zhou, Rui-min Chen, Zhe Wang, Wan-shu Li, Shuo-min Jiang, Guo-xin Hu, Rui-jie Chen. (2015) Determination and pharmacokinetic study of pirfenidone in rat plasma by UPLC–MS/MS. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 981-982 (14). |
| 9. Canchao Jia, Minjuan Yang, Guanlin Xiao, Zhihao Zeng, Lingjie Li, Yangxue Li, Jieyi Jiang, Aili Xu, Jinyan Qiu, Ruiyin Tang, Dongmei Li, Dezheng Jia, Canhui Xie, Guangying Wu, Dake Cai, Xiaoli Bi. (2024) ESL Attenuates BLM-induced IPF in Mice: Dual Mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a Pathways. PHYTOMEDICINE, (155545). |
| 10. Su Qiyan, Feng Yingyue, Guo Jin, Cui Xi, Zhu Jiarui, Yang Jumei, Zhang Sigong. (2025) Pirfenidone alleviates interstitial lung disease in mice by inhibiting neutrophil extracellular trap formation and NLRP3 inflammasome activation. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, |
| 11. Shuyu Ge, Zhenghong Guo, Ting Xiao, Pingping Sun, Bo Yang, Yin Ying. (2024) Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats. MEDIATORS OF INFLAMMATION, 2024 (5573353). |